Patent · US Active

Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subject

US10413590B2 · kind B2 · utility

10Cited by
66References
121Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 1, 2017
Grant dateSep 17, 2019
Priority date—
Expiry dateNov 1, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/66
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to methods of using variants of fibroblast growth factor 19 (FGF19) for reducing body mass in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.